[
  {
    "ts": null,
    "headline": "Cardinal Health (CAH): A Top Pick For The Best Retirement Portfolio",
    "summary": "We recently published the Best Retirement Portfolio for a 65-Year-Old. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against other stocks in the best retirement portfolio. The American retirement system is feeling the strain, with challenges like shrinking fees, underfunded plans, and an aging population slowing […]",
    "url": "https://finnhub.io/api/news?id=65f8b3cde3cdc4d0f796f585dae9e758ff78473b14b677feda2790078ed8b884",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743194797,
      "headline": "Cardinal Health (CAH): A Top Pick For The Best Retirement Portfolio",
      "id": 133527679,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "We recently published the Best Retirement Portfolio for a 65-Year-Old. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against other stocks in the best retirement portfolio. The American retirement system is feeling the strain, with challenges like shrinking fees, underfunded plans, and an aging population slowing […]",
      "url": "https://finnhub.io/api/news?id=65f8b3cde3cdc4d0f796f585dae9e758ff78473b14b677feda2790078ed8b884"
    }
  },
  {
    "ts": null,
    "headline": "Are Medical Stocks Lagging  Cardinal Health (CAH) This Year?",
    "summary": "Here is how Cardinal Health (CAH) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=2296fef6c7833d716f3f6df931502f08a35db3de4f4f69996431ebeeba9dcdd2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743169210,
      "headline": "Are Medical Stocks Lagging  Cardinal Health (CAH) This Year?",
      "id": 133523998,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Here is how Cardinal Health (CAH) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=2296fef6c7833d716f3f6df931502f08a35db3de4f4f69996431ebeeba9dcdd2"
    }
  },
  {
    "ts": null,
    "headline": "IceCure Medical Stock Dips Despite Positive ICESECRET Study Results",
    "summary": "ICCM reports strong kidney cancer cryoablation study results, showcasing 88.7% recurrence-free rates and reinforcing its position in cryoablation technology.",
    "url": "https://finnhub.io/api/news?id=c37fe2aadd881b386ede3ae22964fc01d7c745b1f6d0f2a826cf9e4809e290af",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743167760,
      "headline": "IceCure Medical Stock Dips Despite Positive ICESECRET Study Results",
      "id": 133523842,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "ICCM reports strong kidney cancer cryoablation study results, showcasing 88.7% recurrence-free rates and reinforcing its position in cryoablation technology.",
      "url": "https://finnhub.io/api/news?id=c37fe2aadd881b386ede3ae22964fc01d7c745b1f6d0f2a826cf9e4809e290af"
    }
  }
]